<i>Ent</i>-Kaurane Diterpenoids from <i>Coffea</i> Genus: An Update of Chemical Diversity and Biological Aspects

Coffee is one of the most important beverages in the world and is produced from <i>Coffea</i> spp. beans. Diterpenes with <i>ent</i>-kaurane backbones have been described in this genus, and substances such as cafestol and kahweol have been widely investigated, along with thei...

Full description

Saved in:
Bibliographic Details
Main Authors: Víctor de C. Martins, Maria Alice E. da Silva, Valdir F. da Veiga, Henrique M. G. Pereira, Claudia M. de Rezende
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/30/1/59
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Coffee is one of the most important beverages in the world and is produced from <i>Coffea</i> spp. beans. Diterpenes with <i>ent</i>-kaurane backbones have been described in this genus, and substances such as cafestol and kahweol have been widely investigated, along with their derivatives and biological properties. Other coffee <i>ent</i>-kaurane diterpenoids have been reported with new perspectives on their biological activities. The aim of this review is to update the chemical diversity of <i>ent</i>-kaurane diterpenoids in green and roasted coffee, detailing each new compound and reporting its biological potential. A systematic review was performed using the bibliographic databases (SciFinder, Web of Science, ScienceDirect) and specific keywords such as “coffea diterpenes”, “coffee diterpenes”, “coffee ent-kaurane diterpenes” and “coffee diterpenoids”. Only articles related to the isolation of coffee <i>ent</i>-kaurane compounds were considered. A total of 146 compounds were related to <i>Coffea</i> spp. since the first report in 1932. Different chemical skeletons were observed, and these compounds were grouped as furan-type, oxidation-type, rearrangement-type, lacton-type, and lactam-type, among others. In general, the new coffee diterpenoids showed potential as antidiabetic, antidiapogenic, α-glucosidade inhibition, antiplatelet activity, and Cav.3 inhibitors agents, revealing the possibilities for the design, discovery, and development of new drugs.
ISSN:1420-3049